Cooperative Roles of SDF-1α and EGF Gradients on Tumor Cell Migration Revealed by a Robust 3D Microfluidic Model
暂无分享,去创建一个
Mingming Wu | Melody A. Swartz | Beum Jun Kim | M. Swartz | Mingming Wu | Yoon Soo Kim | Pimkhuan Hannanta-anan | Michelle Chau | Yoonhee Kim | P. Hannanta-anan | Michelle Chau
[1] Douglas A Lauffenburger,et al. Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer. , 2012, Current opinion in cell biology.
[2] L. Lebrun,et al. Diffusion of sucrose and dextran through agar gel membranes. , 1993, Enzyme and microbial technology.
[3] P. Gao,et al. Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. , 2005, Cancer research.
[4] Mingming Wu,et al. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19 , 2011, Proceedings of the National Academy of Sciences.
[5] Jing Wu,et al. Screening of a PKC ζ-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis , 2010, Investigational New Drugs.
[6] J. Schlessinger. The epidermal growth factor receptor as a multifunctional allosteric protein. , 1988, Biochemistry.
[7] L. Bonassar,et al. Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. , 2010, Biomaterials.
[8] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[9] M. Sixt,et al. Rapid leukocyte migration by integrin-independent flowing and squeezing , 2008, Nature.
[10] Jian Zhang,et al. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.
[11] J. Schlessinger,et al. Allosteric regulation of the epidermal growth factor receptor kinase , 1986, The Journal of cell biology.
[12] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[13] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[14] N. Jeon,et al. Biological applications of microfluidic gradient devices. , 2010, Integrative biology : quantitative biosciences from nano to macro.
[15] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[16] James Castracane,et al. A new chemotaxis device for cell migration studies. , 2010, Integrative biology : quantitative biosciences from nano to macro.
[17] Beum Jun Kim,et al. Microfluidics for Mammalian Cell Chemotaxis , 2011, Annals of Biomedical Engineering.
[18] Jeffrey Wyckoff,et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. , 2006, Cancer research.
[19] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[20] J. Zavadil,et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.
[21] R. Bonavia,et al. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. , 2005, Experimental cell research.
[22] Stephanie I. Fraley,et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility , 2010, Nature Cell Biology.
[23] A. Agarwal,et al. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. , 1999, Cancer research.
[24] John S. Condeelis,et al. Chemotaxis in cancer , 2011, Nature Reviews Cancer.
[25] B. Vanhaesebroeck,et al. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. , 2003, Cancer research.
[26] Patrick Gizzi,et al. Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12* , 2008, Journal of Biological Chemistry.
[27] H. El-Samad,et al. Bound attractant at the leading vs. the trailing edge determines chemotactic prowess , 2007, Proceedings of the National Academy of Sciences.
[28] David J Beebe,et al. A platform for assessing chemotactic migration within a spatiotemporally defined 3D microenvironment. , 2008, Lab on a chip.
[29] Mingming Wu,et al. An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies , 2009, Biomedical microdevices.
[30] J. Segall,et al. Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.
[31] B. Mosadegh,et al. Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients , 2008, Biotechnology and bioengineering.
[32] Mingming Wu,et al. A hydrogel-based microfluidic device for the studies of directed cell migration. , 2007, Lab on a chip.
[33] Peter Friedl,et al. Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.
[34] F. Balkwill. The significance of cancer cell expression of the chemokine receptor CXCR4. , 2004, Seminars in cancer biology.
[35] Zigmond Sh. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. , 1977 .
[36] P. Steeg. Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.
[37] Qian Wang,et al. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation , 2005, EMBO reports.
[38] William C Hines,et al. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.
[39] S. Zigmond,et al. ABILITY OF POLYMORPHONUCLEAR LEUKOCYTES TO ORIENT IN GRADIENTS OF CHEMOTACTIC FACTORS , 2003 .
[40] Ulrike Haessler,et al. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[41] D. Lauffenburger,et al. Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration , 2001, The Journal of cell biology.
[42] Francis Lin,et al. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. , 2004, Experimental cell research.
[43] R. Bonavia,et al. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. , 2005, Experimental cell research.
[44] Melody A Swartz,et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. , 2007, Cancer cell.
[45] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[46] Erik Sahai,et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.
[47] J. Galzi,et al. Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1α Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.
[48] Jeffrey Wyckoff,et al. Description and characterization of a chamber for viewing and quantifying cancer cell chemotaxis. , 2005, Cell motility and the cytoskeleton.
[49] Noo Li Jeon,et al. Microfluidic chambers for cell migration and neuroscience research. , 2006, Methods in molecular biology.
[50] M. Poo,et al. Endothelial cell polarization and chemotaxis in a microfluidic device. , 2008, Lab on a chip.
[51] S. Takayama,et al. Receptor differential activation and cooperativity better explain cellular preference for different chemoattractant gradient shapes in an EGFR system. , 2011, Integrative biology : quantitative biosciences from nano to macro.